Home › Companies › Xeris Biopharma Holdings, Inc.
How asset managers voted at Xeris Biopharma Holdings, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Xeris Biopharma Holdings, Inc. | 4 | 226 |
| 2024-2025 | Xeris Biopharma Holdings, Inc. | 5 | 167 |
| 2023-2024 | XERIS BIOPHARMA HOLDINGS INC. | 7 | 140 |
Earlier seasons list this company under the name XERIS BIOPHARMA HOLDINGS INC., as its holders filed it.
Explore Xeris Biopharma Holdings, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 13, 2026.